EGFR x c-MET drugs for Head and Neck Squamous Cell Carcinoma
2 tracked EGFR x c-MET drugs in the Head and Neck Squamous Cell Carcinoma race. The class explanation lives on the EGFR x c-MET page; the full indication pipeline across every mechanism is on the Head and Neck Squamous Cell Carcinoma page.
1 approved / phase 41 Phase 3